MDMA floods the gaps between cells with serotonin and brings the amygdala’s threat response down, hence the trials in post-traumatic stress. In 2024 the US regulator declined approval. Physical risks are serious: overheating, low blood sodium, serotonin syndrome.
Loading brain…